Active Implantable Medical Devices Market Share Analysis of The Top Industry Players
Active Implantable Medical Devices market is projected to reach $28,878.6 million by 2023, growing at a CAGR of 8.0% during 2017 - 2023.
By: P&S Intelligence
Request to Get the Sample Pages at: https://www.psmarketresearch.com/
Geographically, North America has been the largest market for active implantable medical devices, with the U.S. being the larger contributor to the regional market as compared to Canada. The key factor driving the North American active implantable medical devices market are technological advancements, high healthcare expenditure, growing geriatric population, improved healthcare infrastructure and growing prevalence of cardiovascular diseases. The emerging economies in Asia-Pacific, especially China and India, are expected to grow tremendously in future, which is expected to bring the Asia-Pacific market approximately equal to the European market by 2023. Asia-Pacific presents several growth opportunities for the active implantable medical devices manufacturers due to the rapid expansion of healthcare industry in the region.
Key companies in the active implantable medical devices (https://www.psmarketresearch.com/
Some of the other key players in the market include Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC, William Demant Holding A/S, Nurotron Biotechnology Co. Ltd., Sonova Holding AG, and MED-EL.